| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.072 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |